{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:54:20Z","timestamp":1740135260299,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102376"],"award-info":[{"award-number":["82102376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023MD734123"],"award-info":[{"award-number":["2023MD734123"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University","award":["Kryc-Yq-2210"],"award-info":[{"award-number":["Kryc-Yq-2210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-024-00908-8","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T07:01:49Z","timestamp":1728889309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimization of culture conditions for HBV-specific T cell expansion in vitro from chronically infected patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"issue":"9","key":"908_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"BS Sheena","year":"2022","unstructured":"Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abbastabar H, Abdoli A, Abubaker Ali H, Adane MM, et al. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"908_CR2","doi-asserted-by":"crossref","unstructured":"Zheng J-R, Wang Z-L, Feng B. Hepatitis B functional cure and immune response. Front Immunol 2022, 13.","DOI":"10.3389\/fimmu.2022.1075916"},{"issue":"6","key":"908_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","volume":"76","author":"GLH Wong","year":"2022","unstructured":"Wong GLH, Gane E, Lok ASF. How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development? J Hepatol. 2022;76(6):1249\u201362.","journal-title":"J Hepatol"},{"issue":"1","key":"908_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jhep.2019.07.015","volume":"72","author":"N Le Bert","year":"2020","unstructured":"Le Bert N, Salimzadeh L, Gill US, Dutertre CA, Facchetti F, Tan A, Hung M, Novikov N, Lampertico P, Fletcher SP, et al. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B. J Hepatol. 2020;72(1):34\u201344.","journal-title":"J Hepatol"},{"issue":"10","key":"908_CR5","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1172\/JCI121957","volume":"128","author":"L Salimzadeh","year":"2018","unstructured":"Salimzadeh L, Le Bert N, Dutertre CA, Gill US, Newell EW, Frey C, Hung M, Novikov N, Fletcher S, Kennedy PT, et al. PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. J Clin Invest. 2018;128(10):4573\u201387.","journal-title":"J Clin Invest"},{"issue":"9","key":"908_CR6","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1073\/pnas.91.9.3764","volume":"91","author":"LG Guidotti","year":"1994","unstructured":"Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A. 1994;91(9):3764\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"908_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","volume":"150","author":"Y Xia","year":"2016","unstructured":"Xia Y, Stadler D, Lucifora J, Reisinger F, Webb D, H\u00f6sel M, Michler T, Wisskirchen K, Cheng X, Zhang K, et al. Interferon-\u03b3 and Tumor Necrosis Factor-\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without Cytolysis. Gastroenterology. 2016;150(1):194\u2013205.","journal-title":"Gastroenterology"},{"key":"908_CR8","doi-asserted-by":"crossref","unstructured":"Xia Y, Protzer U. Control of Hepatitis B Virus by cytokines. Viruses 2017, 9(1).","DOI":"10.3390\/v9010018"},{"issue":"3","key":"908_CR9","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.4049\/jimmunol.170.3.1183","volume":"170","author":"E Chun","year":"2003","unstructured":"Chun E, Lee J, Cheong HS, Lee KY. Tumor eradication by hepatitis B virus X antigen-specific CD8\u2009+\u2009T cells in xenografted nude mice. J Immunol. 2003;170(3):1183\u201390.","journal-title":"J Immunol"},{"issue":"5","key":"908_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","volume":"68","author":"A Schuch","year":"2019","unstructured":"Schuch A, Salimi Alizei E, Heim K, Wieland D, Kiraithe MM, Kemming J, Llewellyn-Lacey S, Sogukpinar O, Ni Y, Urban S, et al. Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8\u2009+\u2009T cells in chronically HBV-infected patients with low viral load. Gut. 2019;68(5):905\u201315.","journal-title":"Gut"},{"issue":"3","key":"908_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/infdis\/169.3.633","volume":"169","author":"PY Shu","year":"1994","unstructured":"Shu PY, Lin MY, Chang C, Hwang LH, Huang JH, Chang TH, Hu C. Presence of Hepatitis B surface antigen (HBsAg)-specific cytotoxic T cells in asymptomatic HBsAg carriers. J Infect Dis. 1994;169(3):633\u20137.","journal-title":"J Infect Dis"},{"issue":"5","key":"908_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","volume":"68","author":"RC Hoogeveen","year":"2019","unstructured":"Hoogeveen RC, Robidoux MP, Schwarz T, Heydmann L, Cheney JA, Kvistad D, Aneja J, Melgaco JG, Fernandes CA, Chung RT, et al. Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. Gut. 2019;68(5):893\u2013904.","journal-title":"Gut"},{"issue":"3","key":"908_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2018.05.004","volume":"69","author":"F Rinker","year":"2018","unstructured":"Rinker F, Zimmer CL, Honer Zu Siederdissen C, Manns MP, Kraft ARM, Wedemeyer H, Bjorkstrom NK, Cornberg M. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B. J Hepatol. 2018;69(3):584\u201393.","journal-title":"J Hepatol"},{"issue":"24","key":"908_CR14","doi-asserted-by":"publisher","first-page":"12423","DOI":"10.1128\/JVI.76.24.12423-12434.2002","volume":"76","author":"S Urbani","year":"2002","unstructured":"Urbani S, Boni C, Missale G, Elia G, Cavallo C, Massari M, Raimondo G, Ferrari C. Virus-specific CD8\u2009+\u2009lymphocytes share the same effector-memory phenotype but exhibit functional differences in Acute Hepatitis B and C. J Virol. 2002;76(24):12423\u201334.","journal-title":"J Virol"},{"issue":"3","key":"908_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1023\/A:1023366013858","volume":"23","author":"N Shimada","year":"2003","unstructured":"Shimada N, Yamamoto K, Kuroda MJ, Terada R, Hakoda T, Shimomura H, Hata H, Nakayama E, Shiratori Y. HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. J Clin Immunol. 2003;23(3):223\u201332.","journal-title":"J Clin Immunol"},{"issue":"11","key":"908_CR16","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","volume":"78","author":"GJ Webster","year":"2004","unstructured":"Webster GJ, Reignat S, Brown D, Ogg GS, Jones L, Seneviratne SL, Williams R, Dusheiko G, Bertoletti A. Longitudinal analysis of CD8\u2009+\u2009T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol. 2004;78(11):5707\u201319.","journal-title":"J Virol"},{"issue":"6","key":"908_CR17","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","volume":"61","author":"B Bengsch","year":"2014","unstructured":"Bengsch B, Martin B, Thimme R. Restoration of HBV-specific CD8\u2009+\u2009T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol. 2014;61(6):1212\u20139.","journal-title":"J Hepatol"},{"issue":"4","key":"908_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2020.10.034","volume":"74","author":"G Acerbi","year":"2021","unstructured":"Acerbi G, Montali I, Ferrigno GD, Barili V, Schivazappa S, Alfieri A, Laccabue D, Loglio A, Borghi M, Massari M, et al. Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B. J Hepatol. 2021;74(4):783\u201393.","journal-title":"J Hepatol"},{"issue":"1","key":"908_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jhep.2023.02.035","volume":"79","author":"I Montali","year":"2023","unstructured":"Montali I, Ceccatelli Berti C, Morselli M, Acerbi G, Barili V, Pedrazzi G, Montanini B, Boni C, Alfieri A, Pesci M, et al. Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B. J Hepatol. 2023;79(1):50\u201360.","journal-title":"J Hepatol"},{"issue":"2","key":"908_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1172\/JCI92812","volume":"128","author":"L Rivino","year":"2018","unstructured":"Rivino L, Le Bert N, Gill US, Kunasegaran K, Cheng Y, Tan DZM, Becht E, Hansi NK, Foster GR, Su T-H, et al. Hepatitis B virus\u2013specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation. J Clin Invest. 2018;128(2):668\u201381.","journal-title":"J Clin Invest"},{"issue":"2","key":"908_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/j.gastro.2020.04.019","volume":"159","author":"N Le Bert","year":"2020","unstructured":"Le Bert N, Gill US, Hong M, Kunasegaran K, Tan DZM, Ahmad R, Cheng Y, Dutertre CA, Heinecke A, Rivino L, et al. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in patients with chronic Hepatitis B Virus infection. Gastroenterology. 2020;159(2):652\u201364.","journal-title":"Gastroenterology"},{"key":"908_CR22","doi-asserted-by":"crossref","unstructured":"Fu Y-L, Zhou S-N, Hu W, Li J, Zhou M-J, Li X-Y, Wang Y-Y, Zhang P, Chen S-Y, Fan X et al. Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B. Hep Intl 2023.","DOI":"10.1007\/s12072-023-10490-4"},{"issue":"5","key":"908_CR23","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI33402","volume":"118","author":"AR Lopes","year":"2008","unstructured":"Lopes AR, Kellam P, Das A, Dunn C, Kwan A, Turner J, Peppa D, Gilson RJ, Gehring A, Bertoletti A, et al. Bim-mediated deletion of antigen-specific CD8\u2009+\u2009T cells in patients unable to control HBV infection. J Clin Invest. 2008;118(5):1835\u201345.","journal-title":"J Clin Invest"},{"issue":"2","key":"908_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1172\/JCI92812","volume":"128","author":"L Rivino","year":"2018","unstructured":"Rivino L, Le Bert N, Gill US, Kunasegaran K, Cheng Y, Tan DZ, Becht E, Hansi NK, Foster GR, Su TH, et al. Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation. J Clin Invest. 2018;128(2):668\u201381.","journal-title":"J Clin Invest"},{"key":"908_CR25","doi-asserted-by":"crossref","unstructured":"Wen C, Zhou Y, Zhou Y, Wang Y, Dong Z, Gu S, Wang W, Guo L, Jin Z, Zhong S et al. HBV Core-specific CD4\u2009+\u2009T cells correlate with sustained viral control upon off-treatment in HBeAg-positive chronic hepatitis B patients. Antiviral Res 2023, 213.","DOI":"10.1016\/j.antiviral.2023.105585"},{"issue":"8","key":"908_CR26","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"C Boni","year":"2007","unstructured":"Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 2007;81(8):4215\u201325.","journal-title":"J Virol"},{"key":"908_CR27","unstructured":"Chen H. 2023. http:\/\/www.BioRender.com\/u93x213"},{"key":"908_CR28","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3389\/fimmu.2019.01319","volume":"10","author":"PS Sung","year":"2019","unstructured":"Sung PS, Park DJ, Kim JH, Han JW, Lee EB, Lee GW, Nam HC, Jang JW, Bae SH, Choi JY, et al. Ex vivo detection and characterization of Hepatitis B Virus-Specific CD8(+) T cells in patients considered Immune Tolerant. Front Immunol. 2019;10:1319.","journal-title":"Front Immunol"},{"issue":"22","key":"908_CR29","doi-asserted-by":"publisher","first-page":"10986","DOI":"10.1128\/JVI.01124-08","volume":"82","author":"AT Tan","year":"2008","unstructured":"Tan AT, Loggi E, Boni C, Chia A, Gehring AJ, Sastry KS, Goh V, Fisicaro P, Andreone P, Brander C, et al. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol. 2008;82(22):10986\u201397.","journal-title":"J Virol"},{"key":"908_CR30","doi-asserted-by":"publisher","first-page":"105585","DOI":"10.1016\/j.antiviral.2023.105585","volume":"213","author":"C Wen","year":"2023","unstructured":"Wen C, Zhou Y, Zhou Y, Wang Y, Dong Z, Gu S, Wang W, Guo L, Jin Z, Zhong S, et al. HBV Core-specific CD4(+) T cells correlate with sustained viral control upon off-treatment in HBeAg-positive chronic hepatitis B patients. Antiviral Res. 2023;213:105585.","journal-title":"Antiviral Res"},{"issue":"8","key":"908_CR31","doi-asserted-by":"publisher","first-page":"e23330","DOI":"10.1371\/journal.pone.0023330","volume":"6","author":"AJ Gehring","year":"2011","unstructured":"Gehring AJ, Koh S, Chia A, Paramasivam K, Chew VS, Ho ZZ, Lee KH, Maini MK, Madhavan K, Lim SG, et al. Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection. PLoS ONE. 2011;6(8):e23330.","journal-title":"PLoS ONE"},{"issue":"5","key":"908_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/87730","volume":"2","author":"MJ van Stipdonk","year":"2001","unstructured":"van Stipdonk MJ, Lemmens EE, Schoenberger SP. Na\u00efve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol. 2001;2(5):423\u20139.","journal-title":"Nat Immunol"},{"issue":"5","key":"908_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/87720","volume":"2","author":"SM Kaech","year":"2001","unstructured":"Kaech SM, Ahmed R. Memory CD8\u2009+\u2009T cell differentiation: initial antigen encounter triggers a developmental program in na\u00efve cells. Nat Immunol. 2001;2(5):415\u201322.","journal-title":"Nat Immunol"},{"issue":"8","key":"908_CR34","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00262-011-1199-8","volume":"61","author":"MK Brimnes","year":"2012","unstructured":"Brimnes MK, Gang AO, Donia M, Thor Straten P, Svane IM, Hadrup SR. Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3\/CD28 dynabead-induced T cell expansion. Cancer Immunol Immunother. 2012;61(8):1221\u201331.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"908_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11626-018-0273-3","volume":"54","author":"H Xu","year":"2018","unstructured":"Xu H, Wang N, Cao W, Huang L, Zhou J, Sheng L. Influence of various medium environment to in vitro human T cell culture. Vitro Cell Dev Biol Anim. 2018;54(8):559\u201366.","journal-title":"Vitro Cell Dev Biol Anim"},{"issue":"7","key":"908_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3109\/14653240903219114","volume":"11","author":"K Sato","year":"2009","unstructured":"Sato K, Kondo M, Sakuta K, Hosoi A, Noji S, Sugiura M, Yoshida Y, Kakimi K. Impact of culture medium on the expansion of T cells for immunotherapy. Cytotherapy. 2009;11(7):936\u201346.","journal-title":"Cytotherapy"},{"issue":"6","key":"908_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/hgtb.2016.120","volume":"27","author":"TL Lu","year":"2016","unstructured":"Lu TL, Pugach O, Somerville R, Rosenberg SA, Kochenderfer JN, Better M, Feldman SA. A Rapid Cell expansion process for production of Engineered Autologous CAR-T cell therapies. Hum Gene Ther Methods. 2016;27(6):209\u201318.","journal-title":"Hum Gene Ther Methods"},{"key":"908_CR38","doi-asserted-by":"crossref","unstructured":"Canestrari E, Steidinger HR, McSwain B, Charlebois SJ, Dann CT. Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype. J Immunol Res 2019, 2019:3616120.","DOI":"10.1155\/2019\/3616120"},{"issue":"2","key":"908_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1272\/jnms.80.140","volume":"80","author":"F Josh","year":"2013","unstructured":"Josh F, Tobita M, Tanaka R, Orbay H, Ogata K, Suzuki K, Hyakusoku H, Mizuno H. Concentration of PDGF-AB, BB and TGF-\u03b21 as valuable human serum parameters in adipose-derived stem cell proliferation. J Nippon Med Sch. 2013;80(2):140\u20137.","journal-title":"J Nippon Med Sch"},{"issue":"6","key":"908_CR40","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/jcb.20499","volume":"95","author":"YJ Kang","year":"2005","unstructured":"Kang YJ, Jeon ES, Song HY, Woo JS, Jung JS, Kim YK, Kim JH. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem. 2005;95(6):1135\u201345.","journal-title":"J Cell Biochem"},{"issue":"2","key":"908_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","volume":"12","author":"L Gorelik","year":"2000","unstructured":"Gorelik L, Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 2000;12(2):171\u201381.","journal-title":"Immunity"},{"issue":"6","key":"908_CR42","doi-asserted-by":"publisher","first-page":"e65327","DOI":"10.1371\/journal.pone.0065327","volume":"8","author":"E Loggi","year":"2013","unstructured":"Loggi E, Bihl FK, Cursaro C, Granieri C, Galli S, Brodosi L, Furlini G, Bernardi M, Brander C, Andreone P. Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. PLoS ONE. 2013;8(6):e65327.","journal-title":"PLoS ONE"},{"issue":"2","key":"908_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/JLB.5MA0620-023RR","volume":"109","author":"C Chen","year":"2021","unstructured":"Chen C, Jiang X, Liu X, Guo L, Wang W, Gu S, Wen C, Yi X, Tang L, Li Y. Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay. J Leukoc Biol. 2021;109(2):455\u201365.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"908_CR44","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s12072-023-10490-4","volume":"17","author":"YL Fu","year":"2023","unstructured":"Fu YL, Zhou SN, Hu W, Li J, Zhou MJ, Li XY, Wang YY, Zhang P, Chen SY, Fan X, et al. Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B. Hepatol Int. 2023;17(5):1125\u201338.","journal-title":"Hepatol Int"},{"issue":"48","key":"908_CR45","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.3748\/wjg.v16.i48.6145","volume":"16","author":"J Chen","year":"2010","unstructured":"Chen J, Wang Y, Wu XJ, Li J, Hou FQ, Wang GQ. Pegylated interferon \u03b1-2b up-regulates specific CD8\u2009+\u2009T cells in patients with chronic hepatitis B. World J Gastroenterol. 2010;16(48):6145\u201350.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-024-00908-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-024-00908-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-024-00908-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T19:03:19Z","timestamp":1728932599000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-024-00908-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1186\/s12896-024-00908-8","relation":{},"ISSN":["1472-6750"],"issn-type":[{"type":"electronic","value":"1472-6750"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"2 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the World Medical Association Declaration of Helsinki, and all subjects provided written informed consent. This work was approved by the Ethics Committee of The Second Affiliated Hospital of Chongqing Medical University (2021\u2009\u2212\u2009150).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}